ISA 2020 | Goal of Therapy in AL Amyloidosis: What Predicts the Best Outcome?

Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, discusses the goal of therapy in immunoglobulin light chain (AL) amyloidosis and what predicts the best outcome, highlighting that free light chain ratio should not be used as a criterion or endpoint of therapy.